Sustained metabolic improvements in a remotely delivered ketogenic nutrition programme for veterans with type 2 diabetes: A 3‐year observational study
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16525 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Rebecca N Adams und 4 weiteren Autor:innen. Beteiligte Einrichtung: Virta Health Corp, Denver, Colorado, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diet, Ketogenic, Veterans. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
To evaluate the long‐term effectiveness and safety of a remote, medically supervised ketogenic nutrition therapy intervention for Veterans with type 2 diabetes (T2D). Materials and Methods This retrospective observational analysis examined de‐identified medical records of Veterans with T2D who engaged in a remote continuous care intervention. Outcomes were HbA1c, weight, diabetes medication use and cardiometabolic markers (lipids, liver enzymes, kidney function) among those who remained enrolled for 2 or 3 years. Separately, we assessed weight, glucose and medication changes at programme departure among Veterans who discontinued before 2 years. Outcomes were analysed across subgroups. Linear mixed‐effects models and paired t‐tests evaluated changes over time.
Results
Among 640 enrolled Veterans (mean age: 59 years, BMI: 35 kg/m 2 , HbA1c: 8.4%), 310 (49%) remained engaged at 2 years and 197 (33%) at 3 years. At both time points, HbA1c was reduced by approximately 0.8%, alongside decreases in diabetes medication use. Weight decreased by approximately 9% at both 2 and 3 years. Overall, reductions in HbA1c and weight were seen across subgroups. Veterans who discontinued before 2 years experienced metabolic improvements, with greater benefits among those enrolled at least 6 months.
Conclusions
For US Veterans, long‐term participation in a remote ketogenic nutrition therapy intervention was associated with sustained improvements in glycaemic control, weight, medication use and select cardiometabolic markers. A 0.8% HbA1c reduction is associated with meaningful reductions in diabetes‐related complications, highlighting the potential clinical relevance of these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Virta Health Corp, Denver, Colorado, USA.
- Lingo Biowearables, Alameda, California, USA.
- Division of Endocrinology, Department of Medicine, Georgetown University School of Medicine, Washington, DC, USA.
ORCID-Profile: Rebecca N Adams, Shaminie J Athinarayanan
Zitieren
APA
Adams, R. N., Athinarayanan, S. J., Zoller, A. R., McKenzie, A. L., & Ratner, R. E. (2025). Sustained metabolic improvements in a remotely delivered ketogenic nutrition programme for veterans with type 2 diabetes: A 3‐year observational study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16525
Vancouver
Adams RN, Athinarayanan SJ, Zoller AR, McKenzie AL, Ratner RE. Sustained metabolic improvements in a remotely delivered ketogenic nutrition programme for veterans with type 2 diabetes: A 3‐year observational study. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16525
BibTeX
@article{Adams2025,
author = {Adams, Rebecca N and Athinarayanan, Shaminie J and Zoller, Alison R and McKenzie, Amy L and Ratner, Robert E},
title = {Sustained metabolic improvements in a remotely delivered ketogenic nutrition programme for veterans with type 2 diabetes: A 3‐year observational study},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16525}
}
EUVIMED